Could There Be a Better Treatment for MS Relapses? New Findings From Apheresis Procedures May Trigger a Guideline Update
What should you do if a patient with multiple sclerosis suffers an acute relapse, but the standard methylprednisolone treatment does not result in any improvement? As it stands, the guidelines recommend a second cycle of the steroid at a double dose. A German study has now shown that visual, motor, and sensory abilities are retained better through immunoadsorption — an important finding for when updating the current guidelines. [1]
Significant advances have been made over the last 20 years in long-term immunomodulatory therapy of multiple sclerosis. However, the same cannot be said for the treatment of acute relapses, explain Steffen Pfeuffer, MD, and colleagues from the University of Münster in the Journal of Neuroinflammation.Common practice still involves the administration of high-dose intravenous methylprednisolone, 1000 mg daily for 3-5 consecutive days.
Vous désirez lire la suite de cet article ?
Inscrivez-vous